This could be considered as a limitation of the present study, but it may be partially counterbalanced by the new original findings with special emphasis on CD34_CAFs’ different impact on BC molecular subtypes and both CD34_CAFs’ and SMA_CAFs’ interrelation with other stromal components. This evidence concerns the gene CD34 and breast cancer.